Results from the first bimester of word at the Faculty of Veterinary Sciences- UNLP COVID-19 Diagnostic Unit
FCV-UNLP COVID-19 Diagnostic
DOI:
https://doi.org/10.24215/15142590e050Keywords:
SARS-CoV-2, GeneFinder™, N gene, ArgentinaAbstract
The COVID-19 pandemic required rapid development and approval of diagnostic methods and kits. Nasal swab samples (n=1114) were derived to Faculty of Veterinary Sciences- UNLP COVID-19 diagnostic unit by the Buenos Aires Province Ministry of Health during June and July 2020, to perform molecular diagnosis of SARS- CoV-2. Samples of RNA were purified in a type II biosafety cabin and analyzed by real time RT-PCR with the GeneFinder™ kit, which amplifies 3 viral target genes (N, E y RdRp). Of the 1110 samples with positive internal control, 458 (41.2%) were positive (26.9% to all target genes, 4.2% to 2 target genes and almost 10% to one gene, mainly N). Percentage of positive samples remained similar throughout the study period, although the sample number was higher in July (781 samples; 315 positive) compared to June (333 samples; 143 positive). Samples from Berisso, Ensenada and La Plata had significantly lower positive rate than those coming from other counties (27.6% versus 60.7%, respectively). Positivity rate was higher in samples from patients with ≥3 clinical signs (55.6%). It is necessary to conduct inter-laboratory validation studies and standardization of diagnostic methods used in order to obtain reliable and reproducible results.
Downloads
Metrics
References
Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D, Zambrano- Achig P, del Campo R, Ciapponi A, Sued O, Martinez-Garcia L, Rutjes A, Low N, Perez-Molina JA, Zamora J. 2020. False-negative results of initial RT-PCR assays for covid-19: a systematic review. preprint. https://www.medrxiv.org/content/10.1101/2020.04.16.20066787v1
Cheng VCC, Lau SKP, Woo PCY, Yung Yuen K. 2007. Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection. Clinical Microbiology Reviews. 20(4): 660-94. https://doi.org/10.1128/CMR.00023-07
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DGJC, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MPG, Drosten C. 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25(3):pii=2000045. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045
Johnson MC, Saletti-Cuesta L, Tumas N. Emociones, preocupaciones y reflexiones frente a la pandemia del COVID-19 en Argentina. 2020. Ciência & Saúde Coletiva. 25(suppl 1):2447-56. http://dx.doi.org/10.1590/1413-81232020256.1.10472020
Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT, Chaillon A. 2020. Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2. Journal of Medical Virology. 92(6):602–11. https://doi.org/10.1002/jmv.25731
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. 2020. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 22;395(10224):565-74. https://doi.org/10.1016/S0140-6736(20)30251-8
Moore NM, Li H, Schejbal D, Lindsley J, Hayden MK. 2020. Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2. Journal of Clinical Microbiology. 58(8):e00938-20. https://doi.org/10.1128/JCM.00938-20
Ramirez JD, Muñoz M, Hernandez C, Flórez C, Gomez S, Rico A, Pardo L, Barros EC, Paniz-Mondolfi AE. 2020. Genetic Diversity Among SARS- CoV2 Strains in South America may Impact Performance of Molecular Detection. Pathogens. 9(7):E580. https://doi.org/10.3390/pathogens9070580
Rearte A, Baldani AEM, Barcena Barbeira P, Domínguez CS, Laurora MA, Pesce M, Rojas Mena MP, da Cruz Ferreira Silva HH, Hertlein C, Tarragona S, Vizzoti C. 2020. Características epidemiológicas de los primeros 116 974 casos de COVID-19 en Argentina, 2020. Revista Argentina de Salud Pública. 12 Supl COVID-19:e5.
Shi J, Han D, Zhang R, Li J, Zhang R. 2020. Molecular and serological assays for SARS-CoV-2: insights from genome and clinical characteristics. Clinical Chemistry. 66(8):1030-46. https://doi.org/10.1093/clinchem/hvaa122
Watson J, Whiting PF, Brush JE. 2020. Interpreting a covid-19 test result. British Medical Journal. 69:m1808. https://www.bmj.com/content/369/bmj.m1808
Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, Niemeyer D. Jones TC, Vollmar P, Rotche C, Hoelscher M, Bleicker T, Brünink S, Schneider J, Ehmann R, Zwirglmaier K, Drosten C, Wendtner C. 2020. Virological assessment of hospitalized patients with COVID-2019. Nature. 581,465-69. https://doi.org/10.1038/s41586-020-2196-x
Woloshin S, Patel N, Kesselheim AS. 2020. False Negative Tests for SARS- CoV-2 Infection — Challenges and Implications. TheNew England Journal of Medicine. https://doi.org/10.1056/nejmp2015897
Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. 2020. Zoonotic origins of human coronaviruses. International Journal of Biological Sciences. 16(10):1686-97. https://doi.org/10.7150/ijbs.45472
Published
How to Cite
Issue
Section
License
Authors retain the copyright and assign to the journal the right of the first publication, with the with the terms of the Creative Commons attribution license. This type of license allows other people to download the work and share it, as long as credit is granted for the authorship, but does not allow them to be changed in any way or used them commercially.
Analecta Veterinaria by School of Veterinary Sciences, National University of La Plata is distributed under a Creative Commons Attribution-NonCommercial-NoDeriv 4.0 International License.
